AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

Recruitingn/aAges 18 Years - anyAllHospital Las Higueras
💬

In plain words

What the trial is, and whether it could suit you

Acute kidney injury (AKI) is common in critically ill patients and is frequently associated with fluid overload, which can worsen clinical outcomes. Continuous renal replacement therapy (CRRT) allows fluid removal through net ultrafiltration (UFNET), but some patients develop hemodynamic instability or signs of poor tissue perfusion during this process. The purpose of this prospective observational study is to evaluate tolerance to net ultrafiltration in critically ill patients with AKI receiving CRRT. The study will assess clinical, hemodynamic, ultrasound, perfusion, and biochemical parameters before and during fluid removal to identify factors associated with ultrafiltration intolerance. The investigators hypothesize that alterations in hemodynamic, perfusion, and congestion-related parameters can identify patients at increased risk of ultrafiltration intolerance before the developm

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Admission to an Intensive Care Unit * Acute kidney injury according to KDIGO criteria * Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration * Clinical stability considered sufficient to initiate net ultrafiltration according to the treating clinical team Exclusion Criteria: * Chronic kidney replacement therapy prior to ICU admission * Pregnancy * Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period * Inability to perform hemodynamic or perfusion assessment * Extracorporeal membrane oxygenation (ECMO) * Refusal to participate in the study
💊

What it tests

  • Not listed
📍

Where

10 sites
Hospital Cárdio Pulmonar
Salvador, Brazil
Hospital Clínico Regional de Concepción
Concepción, Chile
Complejo Asistencial Dr. Victor Ríos Ruiz
Los Ángeles, Chile
Hospital Clínico Dra. Eloísa Díaz Insunza de La Florida
Santiago, Chile
Hospital Las Higueras de Talcahuano
Talcahuano, Chile
Hospital Universitario San José de Popayán
Popayán, Colombia
Hospital General Enrique Garces
Quito, Ecuador
Ospedale San Bortolo
Vicenza, Italy

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy